Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2020
Archives
Repurposing FDA-approved medicines and gene therapy to combat diabetic retinopathy
Lalit Singh Pukhrambam, PhD, and Ahmed S Ibrahim, PhD from Wayne State University School of Medicine in the U.S. focus here on the importance of combating diabetic retinopathy.
The role of TXNIP in mitochondrial-lysosomal axis dysregulation
Lalit P. Singh, Associate Professor at Wayne State University School of Medicine, explains the role of TXNIP in mitochondrial-lysosomal axis dysregulation in diabetic retinopathy.
A special focus on diabetic retinopathy
Dr Lalit Pukhrambam at Wayne State University School of Medicine is researching how to find a cure for the blinding eye disease of diabetic retinopathy by targeting a protein called thioredoxin-interacting protein (TXNIP), as we find out here.
